Risk appetite buying underpinned on the back of government's efforts to slow the spread of the COVID-19 pandemic and cushion the economy against the impact of a near lockdown of activity across much of the U.S. All three major US indexes soared last week after legislators in Washington passed a $2.2 trillion virus rescue package to help individuals, industries and businesses great and small knocked sideways by coronavirus containment measures.
On Sunday, President Donald Trump ditched the idea of getting the economy back up and running in April and extended stay-at-home guidelines through the end of next month, after the director of the US National Institute of Allergy and Infectious Diseases, Dr Anthony Fauci, who has often contradicted Trump's coronavirus claims, said the pandemic could ultimately kill between 100,000 and 200,000 Americans if mitigation efforts do not succeed.
Adding to bullish sentiment, Italy saw the smallest increase in cases in two weeks, with the World Health Organization voiced hopes that they were seeing a stabilization of the coronavirus trajectory in Italy and Spain as a result of the European lockdowns.
However, market gains capped after news of the sharp increase in coronavirus cases in the United States and in other major economies. Investors are still struggling to gain clarity on the extent of the economic damage wrought by the pandemic. Entire sectors of the global economy have shut down with a swiftness and severity that has drawn comparisons with the opening days of the Great Depression that started in 1929.
Health-care shares were the biggest gainers, after Abbott Laboratories unveiling a five-minute Covid-19 test and Johnson & Johnson announced a vaccine candidate for the virus. Shares of Johnson & Johnson gained 7.9% after it said on Monday that plans to start human testing of its experimental coronavirus vaccine by September and make it ready for emergency use in early 2021. Shares of UnitedHealth Group Inc. also rose 3.6%.
ECONOMIC NEWS: US Pending Home Sales Surges 2.4% In February-- US pending home sales index surged up by 2.4% to 111.5 in February after spiking by 5.3% to an upwardly revised 108.9 in January, the National Association of Realtors reported on Monday. . A pending home sale is one in which a contract was signed but not yet closed. Normally, it takes four to six weeks to close a contracted sale.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
